These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23801218)

  • 1. [Progress of surgical managements in patients with local recurrent rectal cancer].
    Jiang YM; Zhao R
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Jun; 16(6):597-600. PubMed ID: 23801218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of recurrent rectal cancer: practical insights in planning and surgical intervention.
    Yeo HL; Paty PB
    J Surg Oncol; 2014 Jan; 109(1):47-52. PubMed ID: 24122817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Local recurrence and survival rate after rectal cancer operations and multimodal therapy].
    Thomschke D; Kyau-Ummen B; Halbfass HJ
    Chirurg; 2002 Mar; 73(3):245-54. PubMed ID: 11963499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic and predictive factors after surgical treatment for locally recurrent rectal cancer: a single institute experience.
    Asoglu O; Karanlik H; Muslumanoglu M; Igci A; Emek E; Ozmen V; Kecer M; Parlak M; Kapran Y
    Eur J Surg Oncol; 2007 Dec; 33(10):1199-206. PubMed ID: 17400423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality assurance in rectal cancer treatment.
    van de Velde CJ; van den Broek CB
    Dig Dis; 2012; 30 Suppl 2():126-31. PubMed ID: 23207944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radicality of resection and survival after multimodality treatment is influenced by subsite of locally recurrent rectal cancer.
    Kusters M; Dresen RC; Martijn H; Nieuwenhuijzen GA; van de Velde CJ; van den Berg HA; Beets-Tan RG; Rutten HJ
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1444-9. PubMed ID: 19395199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermediate-fraction neoadjuvant radiotherapy for rectal cancer.
    Zhan T; Gu J; Li M; Du C
    Dis Colon Rectum; 2013 Apr; 56(4):422-32. PubMed ID: 23478609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgery for local recurrence of rectal cancer.
    Heriot AG; Tekkis PP; Darzi A; Mackay J
    Colorectal Dis; 2006 Nov; 8(9):733-47. PubMed ID: 17032318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benchmarking trial between France and Australia comparing management of primary rectal cancer beyond TME and locally recurrent rectal cancer (PelviCare Trial): rationale and design.
    Denost Q; Saillour F; Masya L; Martinaud HM; Guillon S; Kret M; Rullier E; Quintard B; Solomon M
    BMC Cancer; 2016 Apr; 16():262. PubMed ID: 27044252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of resection of stage IV rectal cancer with mesorectal excision.
    Law WL; Chu KW
    J Surg Oncol; 2006 Jun; 93(7):523-8. PubMed ID: 16705728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of surgical treatment of local and locoregional recurrence of rectal carcinoma--an analysis of 54 patients].
    Walz MK; Peitgen K; Meyer-Schwickerath M; Hoederath A; Eigler FW
    Zentralbl Chir; 1995; 120(3):236-42; discussion 243-4. PubMed ID: 7754726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical salvage of recurrent rectal cancer after transanal excision.
    Weiser MR; Landmann RG; Wong WD; Shia J; Guillem JG; Temple LK; Minsky BD; Cohen AM; Paty PB
    Dis Colon Rectum; 2005 Jun; 48(6):1169-75. PubMed ID: 15793645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients.
    Bonnen M; Crane C; Vauthey JN; Skibber J; Delclos ME; Rodriguez-Bigas M; Hoff PM; Lin E; Eng C; Wong A; Janjan NA; Feig BW
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1098-105. PubMed ID: 15519780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment strategy for locally recurrent rectal cancer.
    Moriya Y
    Jpn J Clin Oncol; 2006 Mar; 36(3):127-31. PubMed ID: 16598032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total pelvic exenteration for primary locally advanced and locally recurrent rectal cancer.
    Vermaas M; Ferenschild FT; Verhoef C; Nuyttens JJ; Marinelli AW; Wiggers T; Kirkels WJ; Eggermont AM; de Wilt JH
    Eur J Surg Oncol; 2007 May; 33(4):452-8. PubMed ID: 17071043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curative potential of multimodality therapy for locally recurrent rectal cancer.
    Hahnloser D; Nelson H; Gunderson LL; Hassan I; Haddock MG; O'Connell MJ; Cha S; Sargent DJ; Horgan A
    Ann Surg; 2003 Apr; 237(4):502-8. PubMed ID: 12677146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggressive multimodality treatment for locally advanced irresectable rectal cancer.
    Farouk R; Nelson H; Gunderson LL
    Br J Surg; 1997 Jun; 84(6):741-9. PubMed ID: 9189078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrence after transanal excision of T1 rectal cancer: should we be concerned?
    Madbouly KM; Remzi FH; Erkek BA; Senagore AJ; Baeslach CM; Khandwala F; Fazio VW; Lavery IC
    Dis Colon Rectum; 2005 Apr; 48(4):711-9; discussion 719-21. PubMed ID: 15768186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current surgical strategy of locally recurrent rectal cancer].
    Wang X; Jiang Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jul; 20(7):748-752. PubMed ID: 28722086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.